ZLAB - Zai Lab argenx gain as China adds Vyvgart for reimbursement
2023-12-13 08:23:33 ET
More on Zai Lab
- Zai Lab: Strong Growth Amidst Strategic Shifts (Rating Upgrade)
- Zai Lab Limited (ZLAB) Q3 2023 Earnings Call Transcript
- Zai Lab Q3 2023 Earnings Preview
- Seagen, Genmab update Phase 3 data for uterine cancer therapy
- Seeking Alpha’s Quant Rating on Zai Lab
For further details see:
Zai Lab, argenx gain as China adds Vyvgart for reimbursement